Max Healthcare Board Approves FY26 Results, Recommends ₹2 Dividend, Approves Lucknow Hospital & Haryana Shift
Max Healthcare approved FY26 audited financial results. The Board recommended a final dividend of ₹2 per share. Construction of a new hospital in Lucknow and shifting the registered office to Haryana were approved. Radiant Life Care Hospital Foundation's re-classification was also sanctioned, pending regulatory approvals. Mr. Anil Kumar Bhatnagar was re-appointed as Director.
The approval of financial results, dividend recommendation, significant capital expenditure for a new hospital, and corporate restructuring (office shift, promoter re-classification) have a material impact on the company's operations and shareholder value.
The company reported positive financial results, recommended a dividend, and approved key strategic initiatives like hospital construction and office relocation, alongside director re-appointments.
Max Healthcare Institute Limited announced the outcome of its Board meeting held on May 21, 2026. The Board approved the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The company also recommended a final dividend of ₹2 per equity share (20% of face value) for the financial year 2025-26, subject to shareholder approval, to be paid within 30 days of the AGM.
Additionally, the Board approved the re-appointment of M/s. Chandra Wadhwa & Co. as Cost Auditors for FY27. A significant decision was the approval for the re-classification of Radiant Life Care Hospital Foundation from 'Promoter Group' to 'Public' category, pending stock exchange approvals. The construction of Phase-I of Max Super Specialty Hospital in Lucknow, with a capacity for approximately 712 beds, was also approved. Furthermore, the Board approved the shifting of the company's registered office from Mumbai, Maharashtra, to Gurugram, Haryana, subject to member and regulatory approvals.
In terms of directorships, the Board approved the re-appointment of Mr. Anil Kumar Bhatnagar as Non-Executive and Non-Independent Director for a further period of three years, effective from October 1, 2026, to September 30, 2029, subject to member approval at the forthcoming AGM. The Board meeting commenced at 12:07 PM IST and concluded at 3:44 PM IST.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.